Therefore, these results obtained in the model translocant yeast indicate that the human P53 is an energy booster for aneuploid yeast cells and, corroborating previous clinical data, suggest that P53 might be an indicator of cell transformation to AML (24, 25) and its presence predictive of adverse prognosis (22). This evidence concerns the gene TP53 and acute myeloid leukemia.